Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/2001
11/15/2001WO2001015737A3 Method for coupling molecules
11/15/2001WO2001007088A3 Methods for treating therapy-resistant tumors
11/15/2001WO2001006756A3 Use of diphenyliodonium for the activation and protection of cytotoxic lymphocytes
11/15/2001WO2001004344A3 Induction of a th1-like response in vitro
11/15/2001WO2001003717A3 Methods of inducing cell death
11/15/2001WO2001002594A3 DNA CONSTRUCTS BASED ON THE eIF4A GENE PROMOTER
11/15/2001WO2001002550A3 Cell death related drug targets in yeast and fungi
11/15/2001WO2001000880A3 Diagnostics and therapeutics for diseases associated with an il-1 inflammatory haplotype
11/15/2001WO2000078344A8 Prion protein peptides and uses thereof
11/15/2001WO2000063379A3 The p2x3 receptor, methods of altering p2x3 receptor activity and uses thereof
11/15/2001WO2000057865A9 Pharmaceutical compositions comprising cyclic glycerophosphates and analogs thereof for promoting neural cell differentiation
11/15/2001WO2000053232A9 Matriptase, a serine protease and its applications
11/15/2001WO2000047729A9 Deglycosylated kringle 1-5 region fragments of plasminogen and methods of use
11/15/2001WO2000026370A9 Adenine nucleotide translocator (ant) fusion proteins and uses thereof
11/15/2001US20010041923 Patient temperature regulation method and apparatus
11/15/2001US20010041799 Diephenyl carbocyclic thioamide derivatives
11/15/2001US20010041746 Reduce side effect; analgesics
11/15/2001US20010041729 Use of prostaglandin (PGE2) receptor 4 (EP4) selective agonists for the treatment of acute and chronic renal failure
11/15/2001US20010041726 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
11/15/2001US20010041723 Using agonists and antagonists of the nicotinergic acetylcholine receptors of insects such as fleas, lice and flies, on humans and animals
11/15/2001US20010041720 2-Amino-N-((1R)-2-((3R)-3-benzyl-3-(N,N',N' -trimethylhydrazinocarbonyl)piperidin-1-yl)-1-(1H-indol-3-ylmethyl)-2 -oxoethyl)-2-methylpropionamide; increasing rate and extent of growth, milk and wool production
11/15/2001US20010041718 Cis-6-(4-fluoro-phenyl)-5-(4-(2-piperidin-1-yl-ethoxy)-phenyl) -5,6,7,8-tetrahydronaphthalene-2-ol, for example, and other estrogen agonists/antagonists to treat rheumatoid arthritis, colon cancer, wounds, cataracts and skin wrinkles
11/15/2001US20010041713 Cyclooxygenase-2 (COX-2); administering 2-(2-methylpyrid-5-yl),3-(p-methylsulfonylphenyl),5-chloro-pyridine, or salt, hydrate or N-oxide thereof, alone or in combination with other drugs
11/15/2001US20010041711 8-(4,4-Bis(p-fluorophenyl)butyl)-1-phenyl-1,3,8-triazospiro(4.5) decan-4-one, for example; treating pain with reduced side effects of opioid analgesics; affinity for opioid receptor-like (ORL1) receptor
11/15/2001US20010041710 (4R)-1-(4-(4-Fluorophenoxy)benzyl)-2-oxo-imidazolidine-4 -carboxylic acid hydroxyamide, for example; treating various diseases including osteoarthritis, rheumatoid arthritis, cancer, osteoporosis, strokes
11/15/2001US20010041705 Heterocyclic carboxamides
11/15/2001US20010041703 Which are growth hormone secretogogues and increase the level of endogenous growth hormone; treating osteoporosis, congestive heart failure, frailty associated with aging, obesity; accelerating bone fracture repair
11/15/2001US20010041695 Orally administering to a post-menopausal woman a fat soluble vitamin and a fat soluble vitamin absorption increasing effective amount of L-carnitine or salts
11/15/2001US20010041685 Mucin synthesis inhibitors
11/15/2001US20010041681 Therapeutically useful synthetic oligonucleotides
11/15/2001US20010041672 Luteinizing hormone releasing hormone analogs or a combination with antiestrogen which is selected from raloxifen, droloxifen, centchroman or derivatives, useful for treating endometrioses and myomas ( gynecological conditions)
11/15/2001US20010041668 Selecting compound that is functionally equivalent to a gene product expressed in an embryo's extraembryonic tissue, causing the compound to access the cells to stimulate cells to undergo hematopoiesis and vascular growth
11/15/2001US20010041178 Preventing airway mucus production by administration of EGF-R antagonists
11/15/2001US20010041170 Compounds with chelation affinity and selectivity for first transition series elements and their use in cosmetics and personal care products, inhibition of metalloenzymes, and inhibition of reperfusion injury
11/15/2001DE10022925A1 New indole-carboxamide or azepino-indole derivatives and analogs, are poly-ADP ribose polymerase inhibitors useful e.g. for treating neurodegenerative disease, ischemia, epilepsy, tumors, sepsis or diabetes mellitus
11/15/2001DE10021731A1 Cyclipostine, Verfahren zu ihrer Herstellung und Verwendung derselben Cyclipostins, processes for their preparation and use thereof
11/15/2001CA2691739A1 Stabilized formulations of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl) benzo [b]thiophene and salts thereof
11/15/2001CA2415688A1 Enzymatic treatment of whey proteins for the production of antihypertensive peptides, the resulting products and treatment of hypertension in mammals
11/15/2001CA2409758A1 Novel multicyclic compounds and the use thereof
11/15/2001CA2409729A1 5-ht7 receptor antagonists
11/15/2001CA2409720A1 A pharmaceutical composition and method of treatment of diseases of cognitive dysfunction in a mammal
11/15/2001CA2409679A1 Bacterial carboxypeptidase cpg2 variants and their use in gene directed enzyme prodrug therapy
11/15/2001CA2409515A1 Human igm antibodies with the capability of inducing remyelination, and diagnostic and therapeutic uses thereof particularly in the central nervous system
11/15/2001CA2409510A1 Method for detecting growth hormone variations in humans, the variations and their uses
11/15/2001CA2408889A1 Immunosuppressive compositions
11/15/2001CA2408840A1 Myc targets
11/15/2001CA2408732A1 Modified es cells and es cell-specific gene
11/15/2001CA2408665A1 Novel regulator of g protein signalling
11/15/2001CA2408632A1 Ph domain-interacting protein
11/15/2001CA2408622A1 Methods for inhibiting proliferation and inducing apoptosis in cancer cells
11/15/2001CA2408571A1 Mammalian receptor proteins; related reagents and methods
11/15/2001CA2408563A1 Stabilized formulations of 6-hydroxy-3-(4-[2-(piperidin-1-yl) ethoxy]phenoxy)-2-(4-methoxyphenyl) benzo[b]thiophene and salts thereof
11/15/2001CA2408549A1 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
11/15/2001CA2408547A1 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
11/15/2001CA2408448A1 Indazoles substituted with 1,1-dioxoisothiazolidine useful as inhibitors of cell proliferation
11/15/2001CA2408343A1 N-acyltetrahydroisoquinoline derivatives
11/15/2001CA2408297A1 Cancer diagnosis and assays for screening anti-cancer agents
11/15/2001CA2408288A1 Novel substituted diamine derivatives useful as motilin antagonists
11/15/2001CA2408253A1 Compositions, kits, and methods for identification, assessment, prevention, and therapy of psoriasis
11/15/2001CA2408228A1 Method for promoting neovascularization
11/15/2001CA2408213A1 Protein complexes and assays for screening anti-cancer agents
11/15/2001CA2408196A1 Sphingosine kinase and uses thereof
11/15/2001CA2408156A1 Heterobicyclic sulfonamides and their use as platelet adp receptor inhibitors
11/15/2001CA2408106A1 Opioid antagonist compositions and dosage forms
11/15/2001CA2408098A1 Opioid antagonist containing composition for enhancing the potency or reducing adverse side effects of opioid agonists
11/15/2001CA2408002A1 Enzymatic assays for screening anti-cancer agents
11/15/2001CA2407864A1 Lipid metabolism enzymes
11/15/2001CA2407852A1 Ortho-substituted anthranilic acid amides and their use as medicaments
11/15/2001CA2407850A1 Cytoskeleton-associated proteins
11/15/2001CA2407830A1 Amino acid derivatives and their use as medicines
11/15/2001CA2407817A1 Anthranilamides and their use as pharmaceutical agents
11/15/2001CA2406549A1 R-eliprodil for treating glaucoma
11/15/2001CA2406512A1 Pharmaceutical compounds for treating copd
11/15/2001CA2405758A1 Use of compounds having combined dopamine d2, 5-ht1a and alpha adrenoreceptor agonistic action for treating cns disorders
11/15/2001CA2404987A1 (e)-7(4-fluorophenyl)-6isopropyl2-mesylaminopyrimidin-5-y)-(3r,5s)-dihydroxyhept-6-enoic acid.
11/15/2001CA2395314A1 Compounds and methods for modulating cerebral amyloid angiopathy
11/14/2001EP1153931A1 Shortened-chain polynucleotides and process for the preparation thereof
11/14/2001EP1153613A1 Percutaneous absorption preparations of compound having angiotensin ii receptor antagonism
11/14/2001EP1153125A1 Deglycosylated kringle 1-5 region fragments of plasminogen and methods of use
11/14/2001EP1153123A2 Pluripotential cells-2
11/14/2001EP1153035A2 Human lipid-associated proteins
11/14/2001EP1153034A1 Growth hormone secretagogues
11/14/2001EP1153022A1 Prothease inhibitors
11/14/2001EP1153017A1 Bicyclic compounds and their use as integrin receptor ligands
11/14/2001EP1153014A2 Beta-alanine derivatives
11/14/2001EP1153013A2 5-ht1f agonists
11/14/2001EP1152776A1 Biodegradable, injectable oligomer-polymer composition
11/14/2001EP1152772A2 Liposome composition and method for administration of a radiosensitizer
11/14/2001EP1152770A1 Small peptides and methods for treatment of asthma and inflammation
11/14/2001EP1152757A2 Connective tissue softening
11/14/2001EP1152754A1 Topic tricyclic antidepressants as analgesics
11/14/2001EP1152753A1 Combinations of formoterol and fluticasone propionate for asthma
11/14/2001EP1152750A1 Spontaneously dispersible n-benzoyl staurosporine compositions
11/14/2001EP1152731A1 A skin care composition that mediates cell to cell communication
11/14/2001EP0885212B1 Quinoxalinediones
11/14/2001EP0847400B1 Polymorphs of the prodrug 6-n-(l-ala-l-ala)-trovafloxacin
11/14/2001EP0828721B1 2-amino-benzoxazinones for the treatment of viral infections
11/14/2001EP0812198B1 Stabilization of prostaglandin compositions
11/14/2001EP0763037B1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USE THEREOF
11/14/2001EP0762883B1 Pyridylbisphosphonates for use as a therapeutical agent
1 ... 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 ... 1564